Apr 12, 2017

Qualtrics raises pre-IPO round at $2.5 billion valuation

Qualtrics, a Utah-based provider of corporate survey and analytics technology, has raised $180 million in new venture capital funding from existing investors at a $2.5 billion pre-money valuation. Axios spoke with co-founder and CEO Ryan Smith. The quick read:

  • Expect an IPO within the next 18 months.
  • Existing investor Accel, which was the first VC firm into Facebook, has now invested more into Qualtrics than into any other portfolio company.
  • Qualtrics wants its new "experience management" platform to be as essential to companies as WorkDay or Salesforce.
  • Smith thinks many founders romanticize struggles that they never really experienced.

Income statement: Qualtrics, which has been cash-flow positive almost since its 2002 founding, expects to do $250 million in revenue this year.

IPO: "I think good companies that have had some long-term flexibility ― like Twilio and Atlassian ― have been able to do big pre-IPO rounds that offer employees some liquidity, put some cash on the balance sheet, look for acquisitions and garner a valuation that helps for the public next step. And they all did it six to twelve, or 18, months before they went out. Fortunately I think we're one of those."

Employee liquidity: "I want to get to $1 billion in revenue with this team, so we've worked hard to optimize for that."

Product: Future vision is tied up in the company's new XM platform, which is basically a dashboard that integrates customer, product, employee and brand experiences. "The lesson from United is that there's a gap between what executives at a company believe is happening, including the experiences of customers and employees, and what is really happening."

M&A: Some of the proceeds will be used for acquisitions that can enhance XM. For example, last year Qualtrics purchased Statwing, a small startup out of YC that enables Qualtrics run correlation analytics on 300 variables across employee and customer data.

Short cap table: Qualtrics didn't raise its first round of funding until it was 10 years-old, and still has just three institutional investors (Accel, Insight Venture Partners and Sequoia Capital). It considered taking money this time from a mutual fund or other crossover investors, but Smith: (1) Isn't sure there's evidence that such investments actually aid in IPO purchasing; (2) Didn't necessarily want to spend valuable time pitching the company: "I think we've raised a total of $400 million in a week's worth of work… We're super fortunate, but it also reflects how we bootstrapped and waited a long time before raising outside money."

Culture: Smith, who has five children, has worked hard to build a family-friendly culture at Qualtrics, as best-profiled last fall by Fortune. But he also realizes that what works best in the Provo headquarters (which features an ice cream parlor) isn't necessarily right for its large office in Dublin (which features a Guinness pub). More broadly, however, he thinks Qualtrics understands that the Silicon Valley yearning to "go back to the basement" is reflective of young founders who got to begin their professional lives on the ground floor:

"Those of us who really started in the basement and went through that culture know that it freaking sucked... We had great ideas that we couldn't execute on because nobody knew who we were. The idea of going back to that is just the cruelest hamster wheel. We've worked very long and very hard to not go back to the basement, and we want to make sure our culture is better than that, in everything we do, from food to benefits."

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 2 hours ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness the treatment of the novel coronavirus has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow3 hours ago - Health